Down-regulation of NR4A1 in follicular thyroid carcinomas is restored following lithium treatment

Author(s)

Camacho, Cleber P. ^{[1, 2]} ; Latini, Flavia R. M. ^{[1, 2]} ; Oler, Gisele ^{[1, 2]} ; Hojaij, Flavio C. ^[3] ; Maciel, Rui M. B. ^[2] ; Riggins, Gregory J. ^[4] ; Cerutti, Janete M. ^{[1, 2]}

Affiliation

^[1] Univ Fed Sao Paulo, Genet Bases Thyroid Tumors Lab, Div Genet, Dept Morphol, BR-04039032 Sao Paulo, SP - Brazil

^[2] Univ Fed Sao Paulo, Mol Endocrinol Lab, Div Endocrinol, Dept Med, BR-04039032 Sao Paulo, SP - Brazil

^[3] Univ Fed Sao Paulo, Div Head & Neck Surg, BR-04039032 Sao Paulo, SP - Brazil

^[4] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD - USA

• Document type: Journal article
• Source: CLINICAL ENDOCRINOLOGY; v. 70, n. 3, p. 475-483, MAR 2009.
• Web of Science Citations: 15

Abstract

The identification of follicular thyroid adenoma-associated transcripts will lead to a better understanding of the events involved in pathogenesis and progression of follicular tumours. Using Serial Analysis of Gene Expression, we identified five genes that are absent in a malignant follicular thyroid carcinoma (FTC) library, but expressed in follicular adenoma (FTA) and normal thyroid libraries. NR4A1, one of the five genes, was validated in a set of 27 normal thyroid tissues, 10 FTAs and 14 FTCs and three thyroid carcinoma cell lines by real time PCR. NR4A1 can be transiently increased by a variety of stimuli, including lithium, which is used as adjuvant therapy of thyroid carcinoma with (131)I. We tested if lithium could restore NR4A1 expression. The expression of other genes potentially involved in the same signalling pathway was tested. To this end, lithium was used at different concentration (10 mm or 20 mm) and time (2 h and 24 h) and the level of expression was tested by quantitative PCR. We next tested if Lithium could affect cell growth and apoptosis. We observed that NR4A1 expression was under-expressed in most of the FTCs investigated, compared with expression in normal thyroid tissues and FTAs. We also found a positive correlation between NR4A1 and FOSB gene expression. Lithium induced NR4A1 and FOSB expression, reduced CCDN1 expression, inhibited cell growth and triggered apoptosis in a FTC cell line. NR4A1 is under-expressed in most of FTCs. The loss of expression of both NR4A1 and the Wnt pathway gene FOSB was correlated with malignancy. This is consistent with the hypothesis that its loss of expression is part of the transformation process of FTCs, either as a direct or indirect consequence of Wnt pathway alterations. Lithium restores NR4A1 expression, induces apoptosis and reduces cell growth. These findings may explain a possible molecular mechanism of lithium's therapeutic action. (AU)

• FAPESP's process: 05/60330-8 - Molecular markers in diagnosis and prognosis of patients with tumors of the human thyroid: transition from basic to clinical research
• Grantee: Janete Maria Cerutti
• Support Opportunities: Research Projects - Thematic Grants